Evidence-based treatment with semaglutide and tirzepatide — comprehensive metabolic assessment, hormonal profiling, and CGM-guided monitoring by Dr. Abhijit Bhograj, DM Endocrinologist. 18 years of clinical experience. 300,000+ patients.
Dr. Bhograj prescribes and monitors all major GLP-1 receptor agonists. The right choice depends on your metabolic profile, BMI, health goals, and medical history.
Originally approved for Type 2 diabetes, Ozempic delivers significant weight loss as a secondary benefit. Now available as generic semaglutide in India since 2026 patent expiry. Ideal for patients with diabetes and obesity.
The higher-dose semaglutide specifically approved for obesity. Strongest evidence for cardiovascular risk reduction. Recommended for patients with BMI 30+ or BMI 27+ with comorbidities.
Dual GIP/GLP-1 receptor agonist showing the highest weight loss in clinical trials. Up to 22% body weight reduction. The most potent option for patients who need maximum weight loss with endocrinologist supervision.
GLP-1 medications act directly on hormonal and metabolic systems. An endocrinologist is the most qualified doctor to prescribe, monitor, and optimise your treatment.
Obesity often has underlying endocrine causes — thyroid dysfunction, PCOS, cortisol excess, insulin resistance. Dr. Bhograj identifies and treats the root cause, not just the symptom.
Ozempic, Wegovy, or Mounjaro? The choice depends on your hormonal profile, glucose levels, cardiovascular risk, and metabolic baseline. A DM Endocrinologist makes this decision with 18 years of clinical data.
AiHealth Clinic uses continuous glucose monitoring and AI-powered analytics to track your metabolic response to GLP-1 therapy in real time — adjusting treatment faster than monthly check-ups allow.
Medical associations warn against GLP-1 prescriptions by non-specialists. Side effects include GI issues, pancreatitis risk, thyroid concerns, and gallbladder problems. A specialist knows what to watch for and when to intervene.
A structured, medically supervised programme from initial assessment to long-term maintenance.
Complete metabolic assessment: BMI, body composition, hormonal panel (thyroid, insulin, cortisol, PCOS markers), fasting glucose, HbA1c, lipid profile, liver and kidney function.
Dr. Bhograj selects the right GLP-1 medication (Ozempic, Wegovy, or Mounjaro), starting dose, and titration schedule based on your metabolic profile and health goals.
Optional continuous glucose monitoring to track how your body responds to GLP-1 therapy. AI-powered insights show metabolic improvement in real time via AiHealth.clinic.
Regular follow-ups to adjust dose, monitor side effects, track weight and metabolic markers. Most patients see significant results within 12–16 weeks. Long-term maintenance plan included.
Common questions patients ask about GLP-1 weight loss treatment in Bangalore.
AiHealth Clinic, 94/H 9th Cross 13th Main RMV Extension, Bangalore 560080. Dr. Abhijit Bhograj is a DM Endocrinologist who prescribes and monitors Ozempic (semaglutide), Wegovy, and Mounjaro (tirzepatide) for medically supervised weight loss. Call +91 70225 84111 to book.
Clinical trials show: Ozempic/Wegovy (semaglutide) delivers ~15–16% body weight loss; Mounjaro (tirzepatide) delivers up to 22% — over approximately 68–72 weeks. For an 80kg person, that's 12–18kg. Individual results depend on metabolic factors, diet, and exercise, which Dr. Bhograj optimises with CGM monitoring and AI analytics.
Yes. Since semaglutide's patent expired in 2026, multiple generic versions are available in India at significantly lower prices. Dr. Bhograj can prescribe the most cost-effective option based on your needs.
Common side effects include nausea, vomiting, diarrhoea, and constipation — usually mild and temporary during dose titration. Rare but serious risks include pancreatitis, gallbladder issues, and thyroid concerns. This is precisely why specialist supervision matters: Dr. Bhograj monitors for these and adjusts treatment accordingly.
Yes. Wegovy and Mounjaro are approved specifically for obesity, independent of diabetes. Many patients at AiHealth Clinic use GLP-1 therapy purely for medical weight loss. Dr. Bhograj performs full metabolic evaluation to determine if you're a suitable candidate.
Dr. Bhograj is one of the few DM Endocrinologists in Bangalore who specialises in GLP-1 therapy with AI-powered monitoring. He uses CGM data, hormonal profiling, and the MMIQ scoring system to personalise treatment. With 300,000+ patients and 18 years of experience, he treats the hormonal root cause of obesity — not just the number on the scale.
Yes. GLP-1 receptor agonists are prescription medications that require medical evaluation before use. Self-medication is dangerous. Book a consultation with Dr. Bhograj at AiHealth Clinic for proper assessment and prescription.
Book a consultation with Dr. Abhijit Bhograj at AiHealth Clinic, RMV Extension, Bangalore. Specialist-supervised. Science-backed. AI-monitored.
AiHealth Clinic — 94/H, 9th Cross, 13th Main, RMV Extension, Bangalore 560080 · Mon–Sat